Why the study?
Long-standing type 2 diabetes mellitus increases chronic coronary syndrome risk, prompting evaluation of undiagnosed chronic coronary syndrome prevalence and diagnostic strategies during routine care.
What is the prevalence of undiagnosed chronic coronary syndrome and what diagnostic testing strategies are used in adults with long-standing type 2 diabetes mellitus and suspected ischemia?
What is the prevalence of undiagnosed chronic coronary syndrome and what diagnostic testing strategies are used in adults with long-standing type 2 diabetes mellitus and suspected ischemia?
Answers are grounded in this paper and cite their sources.
In patients with long-standing type 2 diabetes and suspected ischemia, undiagnosed chronic coronary syndrome is present in 13.6% and predominantly presents with non-classical symptoms like fatigue and dyspnea rather than angina.
AIMS: Long-standing type 2 diabetes mellitus (DM) increases the risk of chronic coronary syndrome (CCS). We estimated the prevalence of undiagnosed CCS during routine outpatient care and described diagnostic testing strategies. METHODS: This multicenter observational study was conducted in eight diabetes and cardiology outpatient clinics in Greece. Adults with DM ≥10 years and suspected ischemia [angina equivalents and/or ischemic electrocardiographic (ECG) abnormalities] without known CCS underwent joint diabetologist-cardiologist evaluation and appropriate non-invasive and/or invasive testing at physician discretion. RESULTS: Overall, 110 people with type 2 DM (mean age 65.4 years; 47.3% women; mean DM duration 21.3 years) were evaluated. CCS was diagnosed in 15 individuals (13.6%). No patient with CCS reported typical or atypical angina; presentations were mainly angina equivalents, most commonly fatigue (66.7%) and dyspnea (58.3%). Ischemic ECG abnormalities were present in 6/15 (40.0%), including repolarization or conduction changes. Initial tests varied: exercise ECG (33.6%), SPECT/PET (32.7%), and stress echocardiography (28.2%). CONCLUSIONS: This study highlights the diagnostic complexity of detecting CCS in individuals with type 2 DM, particularly due to the prevalence of non-classical symptoms. The findings underscore the importance of a personalized diagnostic approach and multidisciplinary collaboration between diabetologists and cardiologists, to improve cardiovascular risk stratification.
No takes yet. Share an insight, caveat, or question.
Thanopoulou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: